Literature DB >> 15750168

Assessment of liver tissue after radiofrequency ablation: findings with different imaging procedures.

Gerald Antoch1, Florian M Vogt, Patrick Veit, Lutz S Freudenberg, Nina Blechschmid, Olaf Dirsch, Andreas Bockisch, Michael Forsting, Jörg F Debatin, Hilmar Kuehl.   

Abstract

UNLABELLED: Our goal was to assess the typical appearance of normal liver tissue immediately after radiofrequency ablation (RF-ablation) when imaged with contrast-enhanced ultrasound, CT, MRI, 18F-FDG PET, and PET/CT.
METHODS: Nineteen RF-ablation sessions were performed on nontumorous liver tissue of 10 Göttingen Mini Pigs. CT, ultrasound, MRI, 18F-FDG PET, and PET/CT were performed immediately after the intervention. All imaging procedures were evaluated qualitatively for areas of increased contrast enhancement (morphologic imaging) and regions of elevated tracer uptake (functional imaging). Images were assessed quantitatively by determination of ratios (r(p/p)) comparing contrast enhancement/tracer uptake in the periphery of the necrosis with contrast enhancement/tracer uptake of normal liver parenchyma.
RESULTS: On morphologic imaging, an increase in contrast enhancement surrounding the ablative necrosis was detected in all lesions. Quantification of this area of increased contrast enhancement revealed ratios of r(p/p) = 1.57 +/- 0.2 for CT and r(p/p) = 1.57 +/- 0.19 for MRI. On PET and PET/CT, homogeneous tracer utilization was found surrounding all lesions. There were no areas of a focal or rim-like increase in glucose metabolism. The ratio r(p/p) was found to be 1.05 +/- 0.08 for functional data. Histologic examination revealed pooling of blood in the sinusoids of the lesion's periphery that was caused by outflow obstruction due to the central necrosis.
CONCLUSION: On morphologic imaging, a rim-like increase of contrast enhancement was found immediately after RF-ablation resembling peripheral hyperperfusion. This area of contrast enhancement may hamper detection of residual tumor. On the basis of homogeneous tracer distribution surrounding the area of necrosis, PET and PET/CT may serve for early assessment of patients after RF-ablation.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15750168

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  17 in total

1.  Iodine quantification with dual-energy CT: phantom study and preliminary experience with VX2 residual tumour in rabbits after radiofrequency ablation.

Authors:  Y Li; G Shi; S Wang; S Wang; R Wu
Journal:  Br J Radiol       Date:  2013-07-24       Impact factor: 3.039

Review 2.  Combined PET/MRI: a new dimension in whole-body oncology imaging?

Authors:  Gerald Antoch; Andreas Bockisch
Journal:  Eur J Nucl Med Mol Imaging       Date:  2009-03       Impact factor: 9.236

3.  Diagnostic accuracy of 18F-FDG PET/CT for assessing response to radiofrequency ablation treatment in lung metastases: a multicentre prospective study.

Authors:  Françoise Bonichon; Jean Palussière; Yann Godbert; Marina Pulido; Edouard Descat; Anne Devillers; Catherine Meunier; Sophie Leboulleux; Thierry de Baère; Claire Galy-Lacour; Laurent Lagoarde-Segot; Anne-Laure Cazeau
Journal:  Eur J Nucl Med Mol Imaging       Date:  2013-09-17       Impact factor: 9.236

Review 4.  [Modern CT and PET/CT imaging of the liver].

Authors:  J Klasen; T A Heusner; C Riegger; D Reichelt; J Kuhlemann; G Antoch; D Blondin
Journal:  Radiologe       Date:  2011-08       Impact factor: 0.635

5.  Magnetic resonance imaging after radiofrequency ablation in a rodent model of liver tumor: tissue characterization using a novel necrosis-avid contrast agent.

Authors:  Yicheng Ni; Feng Chen; Stefaan Mulier; Xihe Sun; Jie Yu; Willy Landuyt; Guy Marchal; Alfons Verbruggen
Journal:  Eur Radiol       Date:  2006-01-21       Impact factor: 5.315

6.  Positron emission tomography for staging and assessment of tumor response of hepatic malignancies.

Authors:  Robert S Hellman; Arthur Z Krasnow; Gary S Sudakoff
Journal:  Semin Intervent Radiol       Date:  2006-03       Impact factor: 1.513

7.  The current role of PET-CT in the characterization of hepatobiliary malignancies.

Authors:  Ginseppe Garcea; Seok Ling Ong; Guy J Maddern
Journal:  HPB (Oxford)       Date:  2009-02       Impact factor: 3.647

8.  Role of [18F]FDG-PET/CT after radiofrequency ablation of liver metastases: preliminary results.

Authors:  Laura L Travaini; Giuseppe Trifirò; Laura Ravasi; Lorenzo Monfardini; Paolo Della Vigna; Guido Bonomo; Antonio Chiappa; Andrew Mallia; Mahila Ferrari; Franco Orsi; Giovanni Paganelli
Journal:  Eur J Nucl Med Mol Imaging       Date:  2008-03-13       Impact factor: 9.236

9.  The sonographer's role in RFA therapy of liver lesions.

Authors:  S Mandarano; G Mandarano; Jh Sim
Journal:  Biomed Imaging Interv J       Date:  2009-01-01

Review 10.  PET/CT in oncology: for which tumours is it the reference standard?

Authors:  Conor D Collins
Journal:  Cancer Imaging       Date:  2007-10-01       Impact factor: 3.909

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.